No Data
No Data
Express News | Cantor Fitzgerald Reiterates Overweight on Biogen, Maintains $292 Price Target
Biogen Analyst Ratings
Biogen/Eisai's Leqembi Brings Hope To Early Alzheimer's Patients Amid Logistical Challenges
50 Stocks That May See Selling Pressure as Investors Begin Looking to Book Tax Losses
Biogen's Higher Spinraza Dose Shows Better Efficacy in Phase II/III Trial
Pandemic Darling Moderna Needs a Reality Check -- Heard on the Street -- WSJ
No Data
webguybob : The Etsy downgrade surprised me!
105535782 : ok
102242135 Lim : K